In the media 26 Jun 2024 Framework to help curb visceral leishmaniasis in East Africa Health Policy Watch
In the media 25 Jun 2024 Consider This: Dengue vaccine (part 3) — Pandemic lessons: Prevent vaccine inequity Astro Awani
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
In the media 22 Jun 2024 What role does capacity development play in transforming health research? Health Policy Watch
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Stories 23 May 2024 Defying the odds: One doctor’s remarkable journey to helping patients with kala-azar
Viewpoints 18 Feb 2023 Africa is winning the war against Neglected Tropical Diseases Africa Arguments
Viewpoints 30 Jan 2023 Right time to take a stab at innovations to sustain kala-azar elimination The Pioneer
Viewpoints 27 Jan 2023 Eliminating neglected diseases in Africa: there are good reasons for hope The Conversation Africa
Viewpoints 8 Nov 2022 Column by Luis Pizarro and Pedro Bouchon: Working on neglected diseases in Chile La Tercera
Viewpoints 21 Jun 2022 Africa-led progress on neglected tropical diseases needs boost in Kigali African Arguments
Viewpoints 14 Jun 2022 South African approval of 4-in-1 combination ARV treatment for children a global first
Viewpoints 8 Jun 2022 Global Britain has a vital role to play in helping cure neglected diseases The House
Viewpoints 17 Feb 2022 EU-African Union summit – Why we need to invest in clinical research infrastructure in Africa EU Observer
Viewpoints 30 Jan 2022 En tiempos de pandemia, ¿quién se acuerda de las enfermedades olvidadas? El Pais
Viewpoints 29 Jan 2022 Maladies tropicales négligées : les succès méconnus de la recherche congolaise Jeune Afrique
Viewpoints 24 Dec 2021 The moonshot: crowdsourcing to develop the first open-source, generic COVID-19 antiviral pill Health Policy Watch